Tamoxifen has played a vital role in endocrine therapy for the treatment of estrogen receptor–positive breast cancer. We examined the effect of tamoxifen in patients with a thin endometrium in frozen–thawed embryo transfer (FET) cycles and compared the improvement in endometrial thickness (EMT) and pregnancy outcomes stratified by different etiologies of thin endometrium. A total of 226 women were recruited for a new tamoxifen protocol; all had an EMT of less than 7.5 mm in previous cycles, including natural cycle (NC), hormone replacement treatment (HRT), and ovulation induction (OI) cycles. Compared with previous cycles, tamoxifen cycles showed a significantly increased EMT (from 6.11 ± 0.98 mm to 7.87 ± 1.48 mm in the NC group, from 6.24 ± 1.01 mm to 8.22 ± 1.67 mm in the HRT group, and from 6.34 ± 1.03 mm to 8.05 ± 1.58 mm in the OI group; all P < .001). Patients were further divided into 3 groups based on the causes of their thin endometrium: (1) history of intrauterine adhesion (n = 34), (2) history of uterine curettage (n = 141), and (3) polycystic ovary syndrome (PCOS; n = 51). Patients with PCOS obtained the thickest EMT (9.31 ± 1.55 mm), the lowest cycle cancellation rate (11.76%), and the highest rate of clinical pregnancy (60%) and live birth (55.56%) per transfer (P < .001). Multivariable regression analysis showed that EMT was related to live birth (odds ratio: 1.487; 95% confidence interval: 1.172-1.887). A tamoxifen protocol improves EMT in patients after NC, HRT, and OI cycles during FET. Patients with PCOS show the most benefit from tamoxifen and achieve better pregnancy outcomes.
PaulsonRJSauerMVLoboRA. Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril. 1990;53(5):870–874.
2.
JarvelaIYSladkeviciusPKellySOjhaKCampbellSNargundG. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol. 2005;26(7):765–769.
3.
El-ToukhyTCoomarasamyAKhairyM. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril. 2008;89(4):832–839.
4.
ChenMJYangJHPengFHChenSUHoHNYangYS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23(7-8):337–342.
5.
GleicherNVidaliABaradDH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95(6):2113–2123.
WecksteinLNJacobsonAGalenDHamptonKHammelJ. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril. 1997;68(5):927–930.
8.
AcharyaSYasminEBalenAH. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies—a report of 20 cases. Hum Fertil (Camb). 2009;12(4):198–203.
9.
Ledee-BatailleNOlivennesFLefaixJLChaouatGFrydmanRDelanianS. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod. 2002;17(5):1249–1253.
10.
TakasakiATamuraHMiwaITaketaniTShimamuraKSuginoN. Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertil Steril. 2010;93(6):1851–1858.
11.
PourmatroudEZargarMNikbakhtRMoramaziF. A new look at tamoxifen: co-administration with letrozole in intrauterine insemination cycles. Arch Gynecol Obstet. 2013;287(2):383–387.
12.
LE DonneMAlibrandiACianciminoLAzzerboniAChiofaloBTrioloO. Endometrial pathology in breast cancer patients: effect of different treatments on ultrasonographic, hysteroscopic and histological findings. Oncol Lett. 2013;5(4):1305–1310.
13.
ReynoldsKKhouryJSosnowskiJThieJHofmannG. Comparison of the effect of tamoxifen on endometrial thickness in women with thin endometrium (<7 mm) undergoing ovulation induction with clomiphene citrate. Fertil Steril. 2010;93(6):2091–2093.
14.
WangCWHorngSGChenCK. Ovulation induction with tamoxifen and alternate-day gonadotrophin in patients with thin endometrium. Reprod Biomed Online. 2008;17(1):20–26.
15.
SeyedoshohadaeiFZandvakilyFShahgeibiS. Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation. Iran J Reprod Med. 2012;10(6):531–536.
16.
ChenXChenS. Successful pregnancy in recurrent thin endometrium with new uses for an old drug. J IVF Reprod Med Genet. 2013;1(110): Doi:10.4172/jfiv.1000110.
17.
TianXChenXXuL. Effect of tamoxifen on clinical outcome of patients with thin endometrium undergoing frozen-thawed embryo transfer. Chin J Pract Gynecol Obstetr. 2015;31(9):736–740.
18.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
19.
ChenZZhangYLiuJ. China diagnosis criteria of polycystic ovarian syndrome diagnosis [in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2012;47(47):74–75.
MahajanNSharmaS. The endometrium in assisted reproductive technology: how thin is thin?J Hum Reprod Sci. 2016;9(1):3–8.
22.
KasiusASmitJGTorranceHL. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(4):530–541.
23.
SaadatMTruongPTKaderHA. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer: comparison of cohorts treated with and without tamoxifen. Cancer Am Cancer Soc. 2007;110(1):31–37.
24.
LassetCBonadonaVMignotteHBrémondA. Tamoxifen and risk of endometrial cancer. Lancet. 2001;357(9249):66–67.
25.
HuRHilakivi-ClarkeLClarkeR. Molecular mechanisms of tamoxifen-associated endometrial cancer (Review). Oncol Lett. 2015;9(4):1495–1501.
26.
LinSLYanLYZhangXT. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. PLos One. 2010;5(2):e9013.
27.
Williams-BrownMYSalihSMXuX. The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk. J Steroid Biochem Mol Biol. 2011;126(3-5):78–86.
28.
KommossFKarckUPrompelerHPfistererJKirkpatrickCJ. Steroid receptor expression in endometria from women treated with tamoxifen. Gynecol Oncol. 1998;70(2):188–191.
29.
MouritsMJTenHKvan der ZeeAGWillemsePHde VriesEGHollemaH. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol. 2002;55(7):514–519.
30.
ElkasJArmstrongAPohlJCuttittaFMartínezAGrayK. Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen. Obstet Gynecol. 2000;95(5):697–703.
31.
ShangYBrownM. Molecular determinants for the tissue specificity of SERMs. Science. 2002;295(5564):2465–2468.
32.
FongCJBurgoonLDWilliamsKJForgacsALZacharewskiTR. Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice. BMC Genomics. 2007;8:151.
33.
ZhangHMcElrathTTongWPollardJW. The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation. J Endocrinol. 2005;184(1):129–140.
34.
MouritsMJHollemaHDe VriesEGTen HoorKAWillemsePHVan Der ZeeAG. Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium. Hum Pathol. 2002;33(3):341–346.
35.
CookePSBuchananDLYoungP. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A. 1997;94(12):6535–6540.
36.
GiudiceLC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235–244.
37.
ShangKJiaXQiaoJKangJGuanY. Endometrial abnormality in women with polycystic ovary syndrome. Reprod Sci. 2012;19(7):674–683.
38.
IndhavivadhanaS. Hyperandrogenemia is associated with thin endometrium in reproductive-aged Thai women with polycystic ovary syndrome. Asian Biomed. 2013;7(4):545–551.
39.
DasBGuptaKGulatiG. Thin endometrium: a challenge in infertility management. Aogo Bulletin. 2015;15(2):12–15.
40.
HulchiyMNybackaASahlinLHirschbergAL. Endometrial expression of estrogen receptors and the androgen receptor in women with polycystic ovary syndrome: a lifestyle intervention study. J Clin Endocrinol Metab. 2016;101(2):561–571.
41.
ShufaroYSimonALauferNFatumM. Thin unresponsive endometrium—a possible complication of surgical curettage compromising ART outcome. J Assist Reprod Genet. 2008;25(8):421–425.
42.
DeansRAbbottJ. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555–569.
